JSP191 Antibody Targeting Conditioning in SCID Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02963064 |
|
Recruitment Status :
Recruiting
First Posted : November 15, 2016
Last Update Posted : November 18, 2021
|
Sponsor:
Jasper Therapeutics, Inc.
Information provided by (Responsible Party):
Jasper Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | August 2024 |
| Estimated Study Completion Date : | August 2027 |